bisoprolol has been researched along with Connective Tissue Diseases in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Connective Tissue Diseases: A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bisoprolol drug was administered at an initial dose of 1." | 1.40 | [Possible applications bisoprolol for heart rate control in young patients with connective tissue dysplasia]. ( Drokina, OV; Nechaeva, GI, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nechaeva, GI | 1 |
| Drokina, OV | 1 |
1 other study available for bisoprolol and Connective Tissue Diseases
| Article | Year |
|---|---|
[Possible applications bisoprolol for heart rate control in young patients with connective tissue dysplasia].
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Blood Pressure; Bradycardia; Connective T | 2014 |